arrow
L

Laura Massella

pediatric nephrology unit
H指数:29
被引数:3,639

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impaired lymphatic drainage in a child with hydrops fetalis and a novel variant in the PROX1 gene: case report and review of literature

胎儿水肿患儿伴PROX1基因新型变异的淋巴引流障碍:病例报告及文献综述

2026-07-300
OA
COL4A1 and COL4A2-Related Disorders – Clinical Features, Diagnostic Guidelines, and Management.

COL4A1和COL4A2相关疾病——临床特征、诊断指南和管理。

2025-07-020
OA
Diagnostic Yield and Clinical Impact of a Small Genetic Panel for Kidney Disease: A Multicenter, Retrospective European Study

小规模肾脏病遗传检测面板的诊断收益率与临床影响:一项多中心、回顾性欧洲研究

2025-06-180
OA
Insights from ADPedKD, ERKReg and RaDaR registries provide a multi-national perspective on the presentation of childhood autosomal dominant polycystic kidney disease in high- and middle-income countries

ADPedKD、ERKReg和RaDaR登记研究的见解为高收入国家和中等收入国家中儿童常染色体显性多囊肾病的临床表现提供了跨国视角。

2025-03-210
PRE
Renal and Extrarenal Phenotypes in Patients With HNF1B Variants and Chromosome 17q12 Microdeletions
2024-08-013
OAAI
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria (vol 29, pg 1186, 2021)
2023-01-311
OAAI
The 2019 and 2021 International workshops on Alport syndrome (vol 30, 507, 2022)
2023-01-240
OAAI
Phenotypic Variability in Siblings With Autosomal Recessive Polycystic Kidney Disease
2022-07-017
OAAI
The 2019 and 2021 International Workshops on Alport Syndrome
2022-03-0926
OAAI
Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement

可能受益于抗SARS-CoV-2单克隆抗体治疗的儿科患者的资格标准: 意大利社会间共识声明

2022-01-1210
OAAI
Early childhood height-adjusted total kidney volume as a risk marker of kidney survival in ARPKD

儿童早期身高调整的总肾体积作为ARPKD患者肾脏存活的风险指标

2021-11-0412
OAAI
Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants
2021-09-0148
OAAI
Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
2021-04-1578
OAAI
Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children

PROPINE随机对照研究的结果表明,对于儿童类固醇敏感性肾病综合征的复发,不必逐渐减少泼尼松治疗

2021-02-0114
PREAI
Impact of COVID-19 Pandemic in Children with CKD or Immunosuppression

新型冠状病毒肺炎大流行对CKD或免疫抑制儿童的影响

2020-12-1433
OA
Severe neurological outcomes after very early bilateral nephrectomies in patients with autosomal recessive polycystic kidney disease (ARPKD)
2020-09-2912
OAAI